standing of the pattern and timing of ventricular change is imperative. Various studies have noted that the change in ventricular size occurs in the first few postoperative months, but to date no study has investigated the longterm reduction in ventricular size.
Methods

Patient Selection
Following institutional review board approval, a database, including all patients who underwent neuroendoscopic procedures, was formed from medical records and imaging studies. The database was searched for cases of children with aqueductal stenosis due to TPG undergoing neuroendoscopic procedures between 1995 and 2010. The search yielded 22 patients, with 13 having additional follow-up from a previous publication in 2002. 29 Successful treatment outcome was defined as no further interventions for CSF diversion, absence of symptoms of increased ICP, and reduction in ventricular size. The follow-up duration was calculated based on the date of the last clinic note.
Radiological outcomes were compared using 4 images for each patient: preoperative, postoperative, 1-year postoperative, and last follow-up image. Ventricular size was compared by measuring the FOR, which is a validated ratio representing ventricular volume and found to have high interobserver reliability in pediatric patients.
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A radiologist, who was blinded to the purpose of the study, performed all FOR measurements and calculations using MRI or CT scans. Additionally, the area value for each TPG was calculated.
Operative Procedure
After induction of general anesthesia, positioning, and prepping the patient with appropriate sterile technique, the scalp was incised 2 cm off of the midline just anterior to the coronal suture and a bur hole was drilled. The dura was opened and ventricular access was obtained using a free-hand technique. A 12.5-F introducer sheath and trocar were carefully passed into the right frontal horn. The trocar was removed and a 0° rigid neuroendoscope (Aesculap) was introduced and directed toward the foramen of Monro. A midline ostomy was made in the region of the tuber cinereum using closed, blunt, endoscopic forceps. The ostomy was then dilated with an endoscopic spreader, and the scope was advanced through the ostomy into the prepontine cistern, making sure that the membrane of Liliequist was opened as well. The endoscope and introducer sheath were then removed, and the skin was closed in routine fashion. External ventricular drains were not routinely used.
Results
Patient Characteristics
Twenty-two patients (mean age [± SD] was 11.6 ± 3.6 years; range 4-18 years) underwent a total of 27 ETVs. Patient characteristics and individual patient details are shown in Tables 1 and 2 . Three patients (14%) had a history of neurofibromatosis.
Nineteen patients (86%) presented with symptoms or signs of elevated ICP, including headache, nausea, vomiting, blurred vision, lethargy, ataxia, urinary incontinence, concentration difficulty, and papilledema. In 3 patients (14%), hydrocephalus was discovered incidentally on CT scans obtained for minor head trauma; 2 of these patients recalled symptoms related to elevated ICP prior to the trauma. Headache was the most common presenting symptom occurring in 86% of patients, and this was followed by nausea and vomiting (45%) and ataxia (27%). Additionally, 5 patients (22.7%) experienced symptoms of gaze dysfunction or Parinaud syndrome related to tumor invasion of the tectum.
A pathological tissue diagnosis was not routinely obtained, but in 2 patients with dorsally exophytic TPGs surgery was performed: 1 patient underwent a biopsy and the other underwent a suboccipital craniotomy and tumor resection both before and after ETV. The pathological diagnosis was pilocytic astrocytoma in both patients, and each underwent adjuvant radiation therapy.
Clinical Outcome
The initial ETV was successful in 17 (77%) of the 22 patients. Failures occurred at 0.3, 6, 14, 15, and 62 months. All 5 patients underwent repeat ETV, and at the last follow-up, 4 of the 5 repeat ETVs were successful. In the 4 successful repeat ETVs, the stoma was found to be closed or scarred and stenotic. The case in which repeat ETV failed was in a patient who had previously undergone shunt surgery. The shunt had been removed prior to the initial ETV. The initial ETV failed after 0.3 months. On repeat ETV, the arachnoid was seen to occlude the stoma. The repeat ETV failed after 6 days, and a VP shunt was reinserted. Thus, 95% of patients were shunt free at the last follow-up. The mean clinical follow-up for all 22 patients was 63.6 months (range 8-176 months).
Most patients (73%) were symptom free at the last follow-up and no patient had symptoms of elevated ICP. Five patients complained of occasional migraine-quality headaches. One patient developed complex partial seizures 13 years after his initial ETV. Another patient developed a significant tremor after suffering an intratumoral hemorrhage.
Radiological Outcome
Preoperative and postoperative imaging studies were available in 18 (82%) of the 22 patients including 4 (80%) of the 5 cases in which the procedure initially failed. The mean radiological follow-up was 5.4 years at most recent imaging session. The post-ETV FOR was significantly lower than it was at baseline in 89% of patients at the most recent radiological follow-up. The 2 patients with larger FOR values had preexisting ventriculoperitoneal shunts in place before ETV. The mean percentage differences in FOR from baseline compared with postoperative, 1 year, and most recent follow-up images are shown in Table 3 . The majority of the decrease in ventricular size occurred within the 1st year after ETV, with minimal decrease thereafter (Fig. 1 ). There was no significant difference in FOR values between ETV success and failure groups at any time point. An early decrease in FOR was seen on postoperative imaging in 78% of patients and in 89% of the cases in which the procedure was successful. The FOR increased at the time of failure in cases of ETV failure with available imaging (Fig. 2) . The mean baseline TPG size was 2.08 cm 2 among all patients (Table 4 ).
There was no significant difference in baseline TPG size between success and failure groups. The TPG size increased from baseline on the most recent images in 50% of patients. The mean percentage difference in glioma size among all patients was 5.8%. There was no significant difference in mean percentage differences between success and failure groups.
Discussion
In a follow-up to an earlier report from our group, 29 our data continue to support ETV as a durable treatment of hydrocephalus associated with TPG and elucidate * EOM = extraocular motion; FU = follow-up; HA = headache; N = nausea; N/V = nausea and vomiting. long-term radiological changes that should be expected after ETV.
Clinical Outcomes of ETV
Endoscopic third ventriculostomy provides good long-term control in cases of obstructive hydrocephalus; success rates range from 50% to 90% depending on the cause of hydrocephalus. 9 A recent multicenter outcome analysis of 618 ETV-treated children with hydrocephalus found a 66% overall success rate and an 82% success rate in the 62 patients with TPGs. 13 Sacko et al., 22 reporting on the outcome of 368 ETVs performed at their institution, noted an overall success rate of 69% and a success rate of 85% in patients with TPGs. Endoscopic third ventriculostomy avoids many of the complications inherent in VP shunts including overdrainage and infection. Retrospectively, Li et al. 16 compared the outcome of VP surgery and ETV in 32 patients with TPGs. All patients who underwent ETV remained shunt free at follow-up, and only one patient required a redo ETV. The success rate for ETV was 88%. Seventy-eight percent of shunt-treated patients required an additional procedure for a success rate of 22%. Similarly, our success rate was 72%, and 95% of children remained shunt free at the last follow-up. Additionally, 95% of ETVs were successful at 6 months, indicating that the CSF dynamics are responsive to ETV. These results are comparable to our original study in which we reported on 13 patients, all of whom remained shunt free in a median 31-month follow-up period, and only 2 of whom required a repeat ETV. 29 Our updated median follow-up duration in those 13 patients was 87 months. All patients remain shunt free, and only 1 additional patient required a repeat ETV.
Change in Ventricular Size After ETV
Changes in ventricular size after ETV are variable and depend on the chronicity of the disease. 1, 24, 25 Persistent ventriculomegaly has been noted even in the absence of clinical symptoms of hydrocephalus. [24] [25] [26] 28 The clinical significance of this persistent ventriculomegaly is unknown. Some authors have suggested that this could have detrimental neurocognitive consequences. 26 Most studies have used decrease in ventricular size as a sign of success. 4, 12, [24] [25] [26] However, small ventricles do not predict the chance of failure in the future, leaving some authors to question the need for regular follow-up imaging. 4 In our patient cohort, clinical failure coincided with radiological failure in 4 patients for whom imaging was available. It is difficult to retrospectively determine whether clinical failure occurred before or after radiological failure in all patients, but in 1 patient, radiological failure (as determined by an increase in ventricular size) was found soon before clinical failure (nearly 6 months). This finding suggests that although a decrease in ventricular size is not predictive of future failure, an increase in ventricular size can be suggestive of an impending failure. It is important to note that 2 patients, both with shunts prior to ETV, had post-ETV ventricles that were larger than on the functional shunt scan, and this was not indicative of failure. Endoscopic third ventriculostomy after shunt failure, however, is clearly a different entity than primary ETV. Clinical symptoms are most relevant in that scenario as well. Other authors stress the importance of the initial size of the TPG to determine whether follow-up is needed.
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To our knowledge, only 2 other series have reported ventricular size at more than one postoperative interval in patients who underwent ETV. 24, 26 St. George et al. 26 obtained postoperative images in 13 children at 1 week, 3 months, 6 months, 12 months, and 24 months. Volumetric ventricular measurements were made. All patients had obstructive hydrocephalus of various etiologies and were subdivided into those presenting with large ventricles (> 5 times normalized volumes) and those presenting with moderate-size ventricles (< 5 times normalized volumes). The decrease in ventricular size was significantly less in the moderate-size group at each time point. Ventricular size stabilized at between 3 and 6 months in the largesize ventricle group, but the size remained greater than that of normalized values. 26 Santamarta et al. 24 obtained postoperative images in 34 patients at 1 month and another set at greater than 3 months after ETV. A gradual decrease in ventricle size was seen and the decreased size persisted for several months. 24 The findings in these studies are consistent with our results. St. George et al. found that ventricular size decreased in the postoperative period and then stabilized. Santamarta et al. did not have enough time points to demonstrate stabilization in ventricular change. Importantly both studies found a decrease in postoperative ventricular size that did not return to normal levels.
We chose to use the FOR to estimate ventricular size. The FOR is a linear measure that has been shown to correlate well with ventricular volume 18 and is relatively simple and quick to obtain. Other studies have used volu- metric measurements of ventricular size that are more accurate but much less simple to obtain.
Treatment Strategies
The early literature on TPG suggested a poor prognosis similar that of diffuse brainstem gliomas. 23 However, in the late 1980s, TPGs were determined to be a specific clinical entity of midbrain tumors with a characteristically benign clinical course. 5, 17 Pathological data are limited, but one review of the available literature suggests that greater than 80% of these lesions are low-grade astrocytomas. 6 However, these data may be biased because the majority of these lesions do not undergo biopsy; this fact leads some authors to suggest that many of the lesions actually represent hamartomas, 17, 28 which has been supported in some reports of pathological fundings.
11,19 A tissue diagnosis was established in only 2 patients in the present series, and both were found to be pilocytic astrocytomas.
Over the last 20 years, treatment of hydrocephalus has been the mainstay of therapy for TPGs because of their indolent course; however, controversy exists over the role of resection. Two small case series supported the notion that resection provides good long-term clinical outcomes with limited morbidity, 14,21 but most authors have recommended only biopsy or resection to acquire evidence of tumor progression. 3, 8, 10, 15, 27, 29, 30 Tumor size has been correlated with more aggressive behavior, 2, 8, 20 and Ternier et al. 28 stratified patients into 3 groups based on glioma size and maintained a "lower threshold" for resection with larger lesions. There were only 2 patients in our series who underwent biopsy/resection followed by fractionated radiotherapy, and this was due to exophytic, more aggressive growth patterns and, most importantly, clinical symptomatic progression.
Our data suggest that TPGs in children can be successfully managed by ETV alone, even in the presence of a change in the size of TPG. In half of the patients, TPG size increased at most recent imaging compared with baseline, yet an increased incidence of failure was not seen in this group. We reported on 2 patients in whom a tissue diagnosis was obtained. Both patients had exophytic lesions, and 1 required multiple resections. Both of the patients in whom a tissue diagnosis was established also underwent ETV and have done well at follow-up. We found no correlation between TPG size and success of the procedure or aggressiveness of the tumor.
Limitations
The retrospective design of the present study introduces inherent bias by the authors that limits the validity of the data. Also our patient cohort of only 22 patients further limits our data. Particularly because our failure group consisted of only 4 patients, any conclusions about ETV failures should be considered speculative. In addition, because the etiology of hydrocephalus was the same in all of our patients, the success rate of ETV may not be generalizable among all patients with obstructive hydrocephalus. We attempted to follow the growth of TPGs to correlate change in size with clinical and radiological findings, but our method of measuring TPG size was not validated and resulted in considerably inconsistent data.
Conclusions
In our patient cohort ventricular size began to stabilize after approximately 1 year postoperatively. Our data suggest that FORs are a useful method of monitoring for clinical failure. It is currently our practice to obtain routine follow-up images in all patients with TPGs treated with ETV. 
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